United States · FDA National Drug Code directory
TOPIRAMATE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 72603-120_a1168608-1b38-4cbe-92b2-dee1771593e1
- Product NDC
- 72603-120
- Form
- CAPSULE, EXTENDED RELEASE
- Composition / generic term
- topiramate
- Labeler
- NorthStar RxLLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20230101
- Source listing expiry
- 20271231
Source-listed ingredients
- TOPIRAMATE — 25 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (72603-120-01) · 72603-120-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →